RecruitingNCT06943742

Non-Helium Magnetoencephalography in Pediatric Brain Tumors

Non-Helium Magnetoencephalography for Clinical Management of Pediatric Brain Tumors : An Observational Cohort Study

Sponsor

Guangzhou Women and Children's Medical Center

Enrollment

100 participants

Start Date

Nov 5, 2024

Study Type

OBSERVATIONAL

Conditions

Pediatric Brain Tumor

Summary

This observational study aims to evaluate the effectiveness of magnetoencephalography (MEG) in the preoperative assessment of pediatric brain tumors, particularly in determining the extent of resection, and compare it with computed tomography (CT) and magnetic resonance imaging (MRI). The main questions this study aims to answer are: What is the consistency between MEG and CT/MRI in localizing pediatric brain tumors? What is the clinical efficacy of MEG in determining the extent of resection of pediatric brain tumors preoperatively? Participants will: Undergo both MEG and CT/MRI examinations for preoperative assessment, and the extent of tumor resection will be determined by the comprehensive results of the above examinations. Be followed up with MEG and CT/MRI at 1, 3, and 6 months after surgery, along with neurological and quality-of-life assessments.

Eligibility

Min Age: 3 YearsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is using a newer type of brain scan called non-helium magnetoencephalography (MEG) — which detects the tiny magnetic signals from brain activity — to map important brain functions in children with brain tumors before surgery. **You may be eligible if...** - Your child is aged 3–18 years - Your child has been diagnosed with a brain tumor - Your child is able to cooperate with the MEG recording procedure **You may NOT be eligible if...** - Your child has serious coexisting medical conditions or neurological/psychiatric disorders that would interfere with the scan - Your child is taking medications that affect central nervous system function - Your child is not a candidate for surgical treatment - Your child has a progressive neurological disorder Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTMagnetoencephalography plus Computed Tomography/Magnetic Resonance Imaging

Use Magnetoencephalography and Computed Tomography/Magnetic Resonance Imaging in the preoperative assessment of pediatric brain tumors.

Locations(1)

Guangzhou Women and Children's medical center

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06943742

Related Trials

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

NCT039113883 locations

Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)

NCT055219841 location

Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain Tumors

NCT0588788210 locations

High-Intensity Interval Exercise in Young Adult Survivors of Pediatric Brain Tumors: A Pilot Feasibility Study

NCT057408391 location

GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults

NCT070870021 location